SCHEMBL5152415

SCHEMBL5152415

CC(C)Oc1c(C(=O)O)cccc1-c1ccccc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HNF4A P41235 1/20 0.53
FABP3 P05413 1/20 0.45
FABP4 P15090 1/20 0.45
FABP5 Q01469 1/20 0.45
RXRA P19793 1/20 0.44
RXRB P28702 1/20 0.44
ALDH1A1 P00352 5/20 0.44
MYC P01106 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
LMNA P02545 1/20 0.44
MAPT P10636 1/20 0.44
MEN1 O00255 1/20 0.44
KMT2A Q03164 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
BCAT2 O15382 1/20 0.43
NR1H4 Q96RI1 1/20 0.43
IRAK4 Q9NWZ3 1/20 0.42
CHRNB2 P17787 1/20 0.42
CHRNB4 P30926 1/20 0.42
CHRNA3 P32297 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9418424 0.89 ALDH1A1 (0.51) HNF4ARXRARXRBALDH1A1KMT2A
SCHEMBL13376487 0.82 ADRA2A (0.51) RXRARXRBALDH1A1MAPTMEN1
SCHEMBL30394743 0.81 HNF4A (0.58) HNF4AFABP3FABP4FABP5ALDH1A1
SCHEMBL4632581 0.81 HNF4A (0.58) HNF4AFABP3FABP4FABP5ALDH1A1
SCHEMBL30696037 0.80 RXRA (0.48) RXRARXRBALDH1A1MAPTMEN1
SCHEMBL17799595 0.80 HNF4A (0.56) HNF4AFABP3FABP4FABP5ALDH1A1
SCHEMBL11333669 0.79 HNF4A (0.47) HNF4AFABP3FABP4FABP5ALDH1A1
SCHEMBL1358288 0.79 KDM4E (0.63) HNF4AFABP3FABP4FABP5ALDH1A1
SCHEMBL18143536 0.78 HNF4A (0.58) HNF4AFABP3FABP4FABP5ALDH1A1
SCHEMBL2109976 0.78 HNF4A (0.58) HNF4AFABP3FABP4FABP5ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070060573-A1 Acyltryptophanols BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2007-03-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070060573-A1 Acyltryptophanols FSHR, NPY1R, NPY2R HNF4A 3838/4885FABP3 2152/4885FABP4 1851/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.